Page last updated: 2024-11-08

n-palmitoyl-5,6-dipalmitoylcysteinyl-alanyl-glycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-palmitoyl-5,6-dipalmitoylcysteinyl-alanyl-glycine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164053
MeSH IDM0169525

Synonyms (16)

Synonym
pam3cys-ala-gly
117858-54-5
2-[[(2s)-2-[[(2r)-3-[2,3-di(hexadecanoyloxy)propylsulfanyl]-2-(hexadecanoylamino)propanoyl]amino]propanoyl]amino]acetic acid
s-(2,3-bis(palmitoyloxy)propyl)-n-palmitoylcysteinyl-alanyl-glycine
pam(3)-cys-ala-gly
n-palmitoyl-5,6-dipalmitoylcysteinyl-alanyl-glycine
tripalmitoyl-cysteinyl-alanyl-glycine
pam(3)cys-ala-gly
glycine, n-(n-(s-(2,3-bis((1-oxohexadecyl)oxy)propyl)-n-(1-oxohexadecyl)-l-cysteinyl)-l-alanyl)-
palmitoyl-cys((rs)-2,3-di(palmitoyloxy)-propyl)-ala-gly-oh (pam3-l-cys-l-ala-gly-oh)
mfcd00236817
DTXSID50922566
n-{2-[(3-{[2,3-bis(hexadecanoyloxy)propyl]sulfanyl}-1-hydroxy-2-[(1-hydroxyhexadecylidene)amino]propylidene)amino]-1-hydroxypropylidene}glycine
HY-P4802
pam3-cys-ala-gly
CS-0674585

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The lipopeptides N-palmitoyl-(S)-[2,3-bis(palmitoyloxy)-(2RS)- propyl]-(R)-cysteinylalanylglycine, N-palmitoyl-(S)-[2,3-bis(palmitoyloxy)- (2RS)-propyl]-(R)-cysteinylseryl-lysyl-lysyl-lysine and (S)-(1,2- dicarboxyhexadecyl)ethyl-N-palmitoylcysteinylseryl-lysyl-lys yl-lysine stimulated both parameters, but the maximal effects on nitrite formation and the shape of the dose-response curves did not parallel the effects on [Ca2+]i."( Induction and activity of NO synthase in bone-marrow-derived macrophages are independent of Ca2+.
Bessler, W; Busse, R; Hauschildt, S; Kohler, J; Lückhoff, A; Mülsch, A, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.11)18.7374
1990's11 (61.11)18.2507
2000's2 (11.11)29.6817
2010's3 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.00 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]